[en] Access to quality medicines is an essential right of the patients. However, in 2017, the World Health
Organization estimated that 1 in 10 medical products circulating in low- and middle-income countries is either
substandard or falsified. This reinforces the fact that post-marketing surveillance (PMS) of medical products by
strong national regulatory authorities (NRA) is crucial. To achieve an efficient PMS, the NRA need analytical
tools at the inspection, screening, confirmatory and forensics levels to control the physicochemical properties of
the samples.
Among the analytical tools available, Raman spectroscopy is particularly interesting because of its spectral
specificity and the wide variety of acquisition modes available. Handheld devices may be used directly on the
field to confirm the presence of a specific active pharmaceutical ingredient (API) in a formulation [1]. Thanks to
databases of pure ingredients, it is also possible to identify the compound present when a wrong API is present
[2]. Recent developments have extended the applicability of handheld devices to the analysis of fluorescent
chemicals and the analysis through barriers [3]. The detection of substandard medicines is also made possible
with the construction of regression chemometrics models [4].
Benchtop systems and among them imaging systems are particularly useful in the confirmatory and forensic
steps. Indeed, the imaging systems enable the visualization and identification of a large range of both organic
and inorganic compounds used as API or excipients [5]. In addition, thanks to the high spatial resolution, it
allows the detection of trace contaminants. This information may be of particular interest during prosecutions
and the clustering of criminal cases. Nevertheless, the extraction of the relevant information from the raw
measurements requires once again intensive work by highly trained staff.
In conclusion, Raman spectroscopy have particularly interesting features for the PMS of medicines.
Research Center/Unit :
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Sacre, Pierre-Yves ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
De Bleye, Charlotte ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Hubert, Philippe ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM) ; Université de Liège - ULiège > Département de pharmacie > Chimie analytique
Marini Djang'Eing'A, Roland ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM) ; Université de Liège - ULiège > Département de pharmacie > Chimie analytique
Ziemons, Eric ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM) ; Université de Liège - ULiège > Département de pharmacie > Chimie analytique
Language :
English
Title :
Interest of Raman spectroscopy for the detection and analysis of poor-quality medicines
Publication date :
2022
Event name :
9th International Conference on Advanced Applied Raman Spectroscopy (RamanFest2022)